Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 May 2022, 18:24 HKT/SGT
Share:
Metaverse GigaSpace Forms Strategic Partnership with UCOLLEX
The Animoca Brands backed NFT platform will join "Project Spaceport" to bring more brands & IPs to Web3 Metaverse

HONG KONG, May 23, 2022 - (ACN Newswire) - Virtual space metaverse GigaSpace (https://www.gigaspace.io/), today announced it has formed a strategic partnership with UCOLLEX (https://ucollex.io/), an innovative NFT platform focused on art and pop culture collectibles.

UCOLLEX will join "Project Spaceport", an initiative GigaSpace launched with MADworld (https://madworld.io/)previously, with the aim to bring in more intellectual properties and brands into the Web3 space.

Project Spaceport

Project Spaceport will be a cultural space district. Brands will be able to create their own virtual space when the Metaverse launches. For now, they can develop their presence in the Web3 space by having their logos and images cemented permanently on the "Map of the Galaxy".

Following MADworld, UCOLLEX is the second NFT platform joining this initiative.

Other features will help enrich the overall experience in this Space Metaverse. There will be a Museum of Brands in the GigaSpace Metaverse. It will be an innovative way for brands to showcase their products, vision and mission. Another exciting feature is branded avatars. These avatars will have numerous utilities.

Innovative VR Experience

In addition to bringing brands to the metaverse, UCOLLEX will offer their VR technology for brands to craft unforgettable experiences and experiment with new ways to engage consumers in the Museum of Brands.

"This partnership will further our mission of closing the loop between creators and collectors, providing a world where collectors can feel at home and live their passion," said Robert Tran, founder of UCOLLEX.

About UCOLLEX
UCOLLEX is the next-generation creators' platform that wants to make NFTs available to everyone, backed by Animoca Brands: a leader in digital entertainment specializing in blockchain and AI technologies. It has successfully completed a US$10 million Series A funding round led by Animoca Brands and MCP IPX One Fund.

About GigaSpace
GigaSpace is a blockchain-based virtual space metaverse where users can purchase land NFTs to create content and explore worlds. It offers a platform to drive the adoption of Web3 by helping brands and partners build their presence in the metaverse.

https://www.gigaspace.io/
https://twitter.com/Gigaspace2140
https://discord.gg/gigaspace


Topic: Press release summary Sectors: Blockchain Technology, Artificial Intel [AI], Metaverse, Games
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
EESystem Triumphs Again: Courts Deem Jason Shurka's Claims "Baseless" and "Futile"  
Oct 31, 2025 21:45 HKT/SGT
Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers  
Oct 31, 2025 19:56 HKT/SGT
Saudi Arabia Assumes Chairmanship of INTOSAI  
Oct 31, 2025 19:45 HKT/SGT
T-RIZE Strategically Collaborates with Republic and Canton to Launch the First New Construction Real Estate Equity Tokenization Deal on Canton Network, phase one of a $200M plan  
Oct 31, 2025 15:50 HKT/SGT
IPO Watch - High-Margin International Business Scales Up Rapidly: Unpacking Hithium Energy Storage's Global Expansion Ambition Behind its Push for a Hong Kong Listing  
Oct 31, 2025 15:20 HKT/SGT
CIMC Group Announces the First Three Quarter Results for 2025  
Oct 31, 2025 14:16 HKT/SGT
Hong Kong delegation concludes mission in Riyadh  
Oct 31, 2025 11:19 HKT/SGT
The Executive Centre Unveils New Premium Flexible Workspace at One IFC, Central Hong Kong  
Oct 31, 2025 09:19 HKT/SGT
Doubleview Gold Corp Announces Non-Brokered Private Placement of Flow-Through Shares at $1.00 per share along with Non-Flow-Through Units  
Oct 31, 2025 09:09 HKT/SGT
HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus  
Friday, October 31, 2025 8:30:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: